Shree Ganesh Bio-Tech (India) Ltd.
BSE: 539470
₹0.61
₹-0.01
(-1.61%)
As on 18-May-2026IST
Market cap
₹24 Cr
Revenue (TTM)
₹5 Cr
P/E Ratio
64.7
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
0.4 %
-
ROCE
0.6 %
-
Industry P/E
15.93
-
EV/EBITDA
47.3
-
Debt to Equity
0
-
Book Value
₹1.6
-
EPS
₹0
-
Face value
1
-
Shares outstanding
398,624,000
10 Years Aggregate
CFO
₹4.16 Cr
EBITDA
₹15.00 Cr
Net Profit
₹15.58 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
| -1.6 | -11.6 | -3.2 | -34.4 | -16.6 | -36.6 | -- |
|
BSE FMCG
| -7.1 | 2.0 | -1.4 | -9.9 | 1.8 | 7.6 | 9.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
| -41.0 | -39.2 | 20.8 | -79.0 | 23.5 | -8.6 | -2.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
|
0.6 | 24.3 | 5.0 | 0.5 | -19.3 | 0.8 | 64.7 | 0.4 |
| 107.6 | 63.4 | 0.3 | -0.9 | -402.5 | -0.9 | -- | 0.6 | |
| 377.5 | 967.3 | 292.7 | 22.2 | 6.8 | 12.7 | 45 | 5.0 | |
| 171.1 | 117.5 | 121.9 | 25.3 | 5.3 | 5.4 | 16.2 | 1.0 | |
| 342.5 | 158.8 | 157.6 | -7.2 | -0.9 | -6.1 | -- | 1.6 | |
| 404.6 | 14,046.4 | 10,945.6 | 619.5 | 8.3 | 14.4 | 22.5 | 3.1 | |
| 158.3 | 301.2 | 445.1 | 41.6 | 10.9 | 5.6 | 7.2 | 0.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Shree Bio-Tech
Growing of plants for planting
-
Incorporated
1982
-
Chairman
--
-
Managing Director
--
-
Headquarters
Kolkata, West Bengal
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Shree Bio-Tech
What is the current share price of Shree Ganesh Bio-Tech (India) Ltd Today?
The share price of Shree Ganesh Bio-Tech (India) Ltd is ₹0.61 (BSE) as of 18-May-2026 IST. Shree Ganesh Bio-Tech (India) Ltd has given a return of -16.56% in the last 3 years.
What is the current PB & PE ratio of Shree Ganesh Bio-Tech (India) Ltd?
The P/E ratio of Shree Ganesh Bio-Tech (India) Ltd is 64.67 times as on 18-May-2026, a 306 premium to its peers’ median range of 15.93 times.
The P/B ratio of Shree Ganesh Bio-Tech (India) Ltd is 0.38 times as on 18-May-2026, a 79 discount to its peers’ median range of 1.83 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
128.57
|
0.57
|
|
2024
|
67.31
|
0.66
|
|
2023
|
19.96
|
0.65
|
|
2022
|
36.70
|
3.07
|
|
2021
|
37.29
|
4.09
|
What is the 52 Week High and Low of Shree Ganesh Bio-Tech (India) Ltd?
The 52-week high and low of Shree Ganesh Bio-Tech (India) Ltd are Rs 0.94 and Rs 0.54 as of 19-May-2026.
What is the market cap of Shree Ganesh Bio-Tech (India) Ltd?
Shree Ganesh Bio-Tech (India) Ltd has a market capitalisation of ₹ 24 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Shree Ganesh Bio-Tech (India) Ltd?
Before investing in Shree Ganesh Bio-Tech (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.